C1 was very effective in inhibiting murine primary Skp2+/+ ICN T-ALL cells (IC50: 0.62 μM) while showing little toxicity on primary murine BM cells (Fig. S8B–D). The gene discussed is SKP2; the disease is acute lymphoblastic leukemia.